American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

Robert Saddawi-Konefka – San Diego California

This AHNS online physician locator helps you find a match for your medical needs.

Members: How to Modify your profile 

Instructions on using the search:

  • The easiest way to search is to drag and zoom the map below until you are seeing your desired geographical area.  Once there, click on the pins to see member information
  • You may use the geosearch box to autocomplete an area and search that way
  • If you wish to search by other criteria, use the text search box

← Go back

Robert Saddawi-Konefka

UC San Diego Health

  • 25
  • 18

3855 Health Sciences Drive
Rm 2343
San Diego, California 92103
United States
Map It

Email hidden; Javascript is required.

Dr. Saddawi-Konefka is an OHNS resident physician and postdoctoral researcher at UC San Diego. Currently, he is completing an F32-supported fellowship in the laboratory of Dr. Silvio Gutkind at the Moores Cancer Center. Dr. Saddawi-Konefka's research interests include cancer-immune dynamics and the design of translatable, precision immune-oncology therapies for head and neck cancer.

Peer-Reviewed Publications

  1. Saddawi-Konefka, R* et al. Lymphatic-Preserving Treatment Sequencing Unleashes cDC1-Dependent Antitumor Immunity in HNSCC. In press Nat Commun. 2022; 13, 4298 *co-corresponding author
  2. Saddawi-Konefka, R et al. Imaging Biomarkers to Predict Response to Immune Checkpoint Inhibitor Therapy in HNC. In submission
  3. Wu, V., Yung, B., Faraji, F., Saddawi-Konefka, R. et al. A chemogenetic approach reveals a GPCR-Gαs-PKA signaling axis promoting T cell dysfunction and cancer immunotherapy failure. In review Nature Immunology
  4. Gilardi, M., Saddawi-Konefka, R. et al. Microneedle-mediated intratumoral delivery of anti-CTLA-4 promotes cDC1-dependent eradication of oral squamous cell carcinoma with limited irAEs. Mol Cancer Ther. 2022; 21-0234.
  5. Wang, Z.… Saddawi-Konefka, R* et al. Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer. Nat Commun 12, 2383 (2021). *co-corresponding author
  6. Paradis, , Acosta, M., Saddawi-Konefka, R et al. Synthetic Lethal Screens Reveal Co-Targeting FAK and MEK as a Multimodal Precision Therapy for GNAQ-Driven Uveal Melanoma. CCR. 2021; 20-3363
  7. Klebaner, D., Saddawi-Konefka, R et al. Immunotherapy in sinonasal melanoma: treatment patterns and outcomes compared to cutaneous melanoma. 2020; 5, 739–9
  8. Finegersh, A, Moss, WJ, Saddawi‐Konefka, R, et al. Meta‐analysis of risk of occult lymph node metastasis in the irradiated, clinically N0 neck. Head & Neck. 2020; 1– 9.
  9. Stramiello, J. A., Saddawi-Konefka, R et al. The role of 3D printing in pediatric airway obstruction_ A systematic review. IJPO 2020; 132, 109923
  10. Robert Saddawi-Konefka et al.Transient Abducens Nerve Palsy After SP Block Following Endoscopic Sinus Surgery. JAMA-OHNS, 2019; e1–2 .
  11. Parthasarathy, V., Snyder, B., & Robert Saddawi-Konefka. A Lot to Choke on: Case of Adult Epiglottitis with Concurrent Peritonsillar Abscess in a Patient with a Sore Throat. JEM, 2018; 55 (6), 841–844
  12. Ruth Seelige, Robert Saddawi-Konefka et al. IL-17D and Nrf2 expression protects from MCMV infection. Nature Scientific Reports. 2018; 8, 13670-84
  13. Robert Saddawi-Konefka et al. Expression and Significance of IL-17D and CD163 in Epithelial Ovarian Cancer. J Gyn Obstet 2018; 2 (1:027) .
  14. Brittany N. Burton, Sapideh Gilani, Milli Desai, Robert Saddawi-Konefka et al. Perioperative Risk Factors Associated with Outcomes Following Pediatric Inpatient Sinus Surgery. Annals of Otology, Rhinology & Laryngology 2018; 128, 504-521
  15. Robert Saddawi-Konefka et al. Inverted schneiderian papilloma of the supraglottis: Case report. The Laryngoscope 2017; 5, 96–3.
  16. Robert Saddawi-Konefka et al. Nrf2 Induces IL-17D to Mediate Tumor and Virus Surveillance. Cell Reports 2016; 16 (9), 2348–2358.
  17. O’Sullivan T, Robert Saddawi-Konefka et al. Interleukin-17D mediates tumor rejection through recruitment of NK cells. Cell Reports 2014; 7:989-98
  18. Robert Saddawi-Konefka** & T O’Sullivan** et al. Cancer immunoediting by the innate immune system in the absence of adaptive immunity JEM 2012; 209:1869-82 ** co-first author

Reviews and Book Chapters

  1. Robert Saddawi-Konefka*, et al. HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer. The Cancer Journal: The Journal of Principles & Practice of Oncology. 2022; 28, 339-345 *co-corresponding author
  2. Robert Saddawi-Konefka, et al. Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities. Frontiers in Oncology. 2021; 11, 738626
  3. Robert Saddawi-Konefka, Bui JD. Chapter 29: Tumor Antigen Profiling. Cancer Immunotherapy Principles and Practice, 2nd Edition. 2021; 498–510
  4. Robert Saddawi-Konefka, Watson, D. Nonsurgical Treatment of Keloids and Hypertrophic Scars. Facial Plast Surg; 2019 35, 260–266.
  5. Robert Saddawi-Konefka, Bui JD. Chapter 29: Tumor Antigen Profiling. Cancer Immunotherapy Principles and Practice. 2017; 489–502.
  6. Robert Saddawi-Konefka et al. Tumor-expressed IL-17D recruits NK cells to reject tumors. Oncoimmunology 2014; 3:12
  7. Robert Saddawi-Konefka, Crawford, J. R. Chronic viral infection and primary central nervous system malignancy. J NeuroI Pharm 2010; 5:387–403